🇺🇸 Busulfan/Cyclophosphamide in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cytomegalovirus Infection Reactivation — 2 reports (18.18%)
  2. Activated Partial Thromboplastin Time — 1 report (9.09%)
  3. Acute Graft Versus Host Disease — 1 report (9.09%)
  4. Acute Kidney Injury — 1 report (9.09%)
  5. Acute Lymphocytic Leukaemia Recurrent — 1 report (9.09%)
  6. Anaemia — 1 report (9.09%)
  7. Bk Virus Infection — 1 report (9.09%)
  8. Cardiac Septal Hypertrophy — 1 report (9.09%)
  9. Chronic Graft Versus Host Disease — 1 report (9.09%)
  10. Cystitis Haemorrhagic — 1 report (9.09%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Busulfan/Cyclophosphamide approved in United States?

Busulfan/Cyclophosphamide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Busulfan/Cyclophosphamide in United States?

Tel-Aviv Sourasky Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.